Fixing the antimicrobial market

CGD’s working group, A New Grand Bargain to Improve the Antimicrobial Market for Human Health, explores how to improve the market for antimicrobials and increase access, stewardship, and innovation, particularly in low- and middle-income countries.

More from the Series

Blog Post

Why We Need a New Grand Bargain for How the World Buys Antibiotics

Katherine Klemperer et al.
September 26, 2022
Antimicrobial resistance is a major global problem. Today, drug resistant infections kill an estimated 1.27 million people per year, and low- and middle-income countries bear the brunt of AMR-related deaths and illness. Changing how we buy antimicrobials can help solve the problem.
Blog Post

Building Better Purchasing Systems for Antimicrobials
Anthony McDonnell et al.
June 28, 2022
CGD has set up a working group to examine different ways to purchase antimicrobials in LMICs in order to identify actionable policies to improve access and stewardship for key products and increase funding for research into new ones. We are launching today the Working Group’s first working paper.